Non-neurological organ dysfunction in neurocritical care: Impact on outcome and etiological considerations

Current Opinion in Critical Care

Volumn 11, Issue 2, 2005, Pages 139-143

  Zygun, David ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b FOOTHILLS HOSPITAL   (Canada)

Author keywords

Cerebral hemorrhage; Critical care; Head injury; Neurocritical care; Organ dysfunction

Indexed keywords

ACTIVATED PROTEIN C; ADRENALIN; ANTIBIOTIC AGENT; BARBITURIC ACID DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CATECHOLAMINE; CEFUROXIME; DOBUTAMINE; DOPAMINE; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT RESPIRATORY DISTRESS SYNDROME; BRAIN INJURY; BRAIN PERFUSION; CATECHOLAMINE RELEASE; CLINICAL TRIAL; CRITICAL ILLNESS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DRUG UTILIZATION; HUMAN; HYPOTHERMIA; IMMUNE DEFICIENCY; INFECTION RISK; INTENSIVE CARE UNIT; INTRACRANIAL HYPERTENSION; MULTIPLE ORGAN FAILURE; NEUROLOGIC DISEASE; NON NEUROLOGICAL ORGAN DYSFUNCTION; OUTCOMES RESEARCH; PATIENT CARE; PERFUSION PRESSURE; POSITIVE END EXPIRATORY PRESSURE; PRACTICE GUIDELINE; PREDICTION; PROGNOSIS; REVIEW; RISK FACTOR; SCORING SYSTEM;

BRAIN INJURIES; CARDIOVASCULAR DISEASES; CRITICAL CARE; HUMANS; MULTIPLE ORGAN FAILURE; RESPIRATORY TRACT DISEASES;

EID: 16844366784     PISSN: 10705295     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ccx.0000155356.86241.c0     Document Type: Review

References (63)

1. Gruber A, Reinprecht A, Illievich UM, et al. Extracerebral organ dysfunction and neurologic outcome after aneurysmal subarachnoid hemorrhage. Crit Care Med 1999; 27:505-514. This paper identifies the association of non-neurological organ dysfunction and outcome in subarachnoid hemorrhage.
2. Zygun DA, Doig CJ, Gupta AK, et al. Non-neurological organ dysfunction in neurocritical care. J Crit Care 2003; 18:238-244.
3. Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996; 22:707-710.
4. Holland MC, Mackersie RC, Morabito D, et al. The development of acute lung injury is associated with worse neurologic outcome in patients with severe traumatic brain injury. J Trauma 2003; 55:106-111. This study defines the importance of acute lung injury in patients with head injury.
5. Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149(3 Pt 1): 818-24.
6. Zygun DA, Kortbeek UB, Fick GH, et al. Non-neurologic organ dysfunction in severe traumatic brain injury. Crit Care Med 2005 (in press).
7. Burch GE, Meyers R, Abildskov JA. A new electrocardiographic pattern obseved in cerebrovascular accidents. Circulation 1954; 9:719-723.
8. Parr MJ, Finfer SR, Morgan MK. Reversible cardiogenic shock complicating subarachnoid haemorrhage. BMJ 1996; 313:681-683.
9. Mayer SA, Fink ME, Homma S, et al. Cardiac injury associated with neurogenic pulmonary edema following subarachnoid hemorrhage. Neurology 1994; 44:815-820.
10. Kono T, Morita H, Kuroiwa T, et al. Left ventricular wall motion abnormalities in patients with subarachnoid hemorrhage: neurogenic stunned myocardium. J Am Coll Cardiol 1994; 24:636-640.
11. Schell AR, Shenoy MM, Friedman SA, et al. Pulmonary edema associated with subarachnoid hemorrhage. Evidence for a cardiogenic origin. Arch Intern Med 1987; 147:591-592.
12. Szabo MD, Crosby G, Hurford WE, et al. Myocardial perfusion following acute subarachnoid hemorrhage in patients with an abnormal electrocardiogram. Anesth Analg 1993; 76:253-258.
13. Raymer K, Choi P. Concurrent subarachnoid haemorrhage and myocardial injury. Can J Anaesth 1997; 44:515-519.
14. Naredi S, Lambert G, Eden E, et al. Increased sympathetic nervous activity in patients with nontraumatic subarachnoid hemorrhage. Stroke 2000; 31; 901-906.
15. Elrifai AM, Bailes JE, Shih SR, et al. Characterization of the cardiac effects of acute subarachnoid hemorrhage in dogs. Stroke 1996; 27:737-741; discussion 741-2.
16. Connor RC. Myocardial damage secondary to brain lesions. Am Heart J 1969; 78:145-148.
17. Zaroff JG, Rordorf GA, Ogilvy CS, et al. Regional patterns of left ventricular systolic dysfunction after subarachnoid hemorrhage: evidence for neurally mediated cardiac injury. J Am Soc Echocardiogr 2000; 13:774-779. This paper identifies a specific pattern of myocardial injury following subarachnoid hemorrhage.
18. Dujardin KS, McCully RB, Wijdicks EF, et al. Myocardial dysfunction associated with brain death: clinical, echocardiographic, and pathologic features. J Heart Lung Transplant 2001; 20:350-357.
19. Shanahan WT. Acute pulmonary edema as a complication of epileptic seizures. NY Med J 1908; 37:54-56.
20. Macmillan CS, Grant IS, Andrews PJ. Pulmonary and cardiac sequelae of subarachnoid haemorrhage: time for active management? Intensive Care Med 2002; 28:1012-1023. An excellent and comprehensive review of the cardiopulmonary complications of subarachnoid hemorrhage.
21. Smith WS, Matthay MA. Evidence for a hydrostatic mechanism in human neurogenic pulmonary edema. Chest 1997; 111:1326-1333.
22. Davidson JT, Charuzi I. Epinephrine-induced changes in the pulmonary pressure-volume curve of the intact and hypovolemic rabbit. Chest 1973; 63:250-253.
23. Ducker TB, Simmons RL. Increased intracranial pressure and pulmonary edema. 2. The hemodynamic response of dogs and monkeys to increased intracranial pressure. J Neurosurg 1968; 28:118-123.
24. Touho H, Karasawa J, Shishido H, et al. Neurogenic pulmonary edema in the acute stage of hemorrhagic cerebrovascular disease. Neurosurgery 1989; 25:762-768.
25. Mathiesen T, Andersson B, Loftenius A, et al. Increased interleukin-6 levels in cerebrospinal fluid following subarachnoid hemorrhage. J Neurosurg 1993; 78:562-567.
26. Kikuchi T, Okuda Y, Kaito N, et al. Cytokine production in cerebrospinal fluid after subarachnoid haemorrhage. Neurol Res 1995; 17:106-108.
27. Bell MJ, Kochanek PM, Doughty LA, et al. Comparison of the interleukin-6 and interleukin-10 response in children after severe traumatic brain injury or septic shock. Acta Neurochir Suppl (Wien) 1997; 70:96-97.
28. Kossmann T, Hans VHJ, Lenzlinger PM. Analysis of immune mediator production following traumatic brain injury. In: Traber D, editor. Shock, Sepsis, and Organ Failure-Brain Damage Secondary to Hemorrhagic-Traumatic Shock, Sepsis, and Traumatic Brain Injury Fifth Wiggers Bernard Conference 1996. Berlin: Springer-Verlag; 1997. p. 263-304.
29. Hirashima Y, Nakamura S, Endo S, et al. Elevation of platelet activating factor, inflammatory cytokines, and coagulation factors in the internal jugular vein of patients with subarachnoid hemorrhage. Neurochem Res 1997; 22:1249-1255.
30. McKeating EG, Andrews PJ, Signorini DF, et al. Transcranial cytokine gradients in patients requiring intensive care after acute brain injury. Br J Anaesth 1997; 78:520-523.
31. van der Sande JJ, Veitkamp JJ, Boekhout-Mussert RJ, et al. Head injury and coagulation disorders. J Neurosurg 1978; 49:357-365.
32. Bredbacka S, Edner G. Soluble fibrin and D-dimer as detectors of hypercoagulability in patients with isolated brain trauma. J Neurosurg Anesthesiol 1994; 6:75-82.
33. Attar S, Boyd D, Layne E, et al. Alterations in coagulation and fibrinolytic mechanisms in acute trauma. J Trauma 1969; 9:939-965.
34. Muller-Berghaus G. Pathophysiologic and biochemical events in disseminated intravascular coagulation: dysregulation of procoagulant and anticoagulant pathways. Semin Thromb Hemost 1989; 15:58-87.
35. Gando S, Nakanishi Y, Kameue T, et al. Soluble thrombomodulin increases in patients with disseminated intravascular coagulation and in those with multiple organ dysfunction syndrome after trauma: role of neutrophil elastase. J Trauma 1995; 39:660-664.
36. Takahasi H, Urano T, Nagai N, et al. Neutrophil elastase may play a key role in developing symptomatic disseminated intravascular coagulation and multiple organ failure in patients with head injury. J Trauma 2000; 49:86-91.
37. Robertson CS, Valadka AB, Hannay HJ, et al. Prevention of secondary ischemic insults after severe head injury. Crit Care Med 1999; 27:2086-2095.
38. Contant CF, Valadka AB, Gopinath SP, et al. Adult respiratory distress syndrome: a complication of induced hypertension after severe head injury. J Neurosurg 2001; 95:560-568. This study identifies risk factors for ARDS derived from a randomized trial comparing, in part, two CPP thresholds.
39. Quattrocchi KB, Frank EH, Miller CH, et al. Suppression of cellular immune activity following severe head injury. J Neurotrauma 1990; 7:77-87.
40. Stover JF, Stocker R. Barbiturate coma may promote reversible bone marrow suppression in patients with severe isolated traumatic brain injury. Eur J Clin Pharmacol 1998; 54:529-534.
41. Loop T, Humar M, Pischke S, et al. Thiopental inhibits tumor necrosis factor alpha-induced activation of nuclear factor kappaB through suppression of kappaB kinase activity. Anesthesiology 2003; 99:360-367. This paper identifies the mechanism of barbiturate-induced immunosupression.
42. Bronchard R, Albaladejo P, Brezac G, et al. Early onset pneumonia: risk factors and consequences in head trauma patients. Anesthesiology 2004; 100:234-239. An excellent study of pneumonia following traumatic brain injury.
43. Henderson WR, Dhingra VK, Chittock DR, et al. Hypothermia in the management of traumatic brain injury. A systematic review and meta-analysis. Intensive Care Med 2003; 29:1637-1644.
44. Piek J, Chesnut RM, Marshall LF, et al. Extracranial complications of severe head injury. J Neurosurg 1992; 77:901-907.
45. Hsieh AH, Bishop MJ, Kubilis PS, et al. Pneumonia following closed head injury. Am Rev Respir Dis 1992; 146:290-294.
46. Berrouane Y, Daudenthun I, Riegel B, et al. Early onset pneumonia in neurosurgical intensive care unit patients. J Hosp Infect 1998; 40:275-280.
47. Laffey JG, O'Croinin D, McLoughlin P, et al. Permissive hypercapnia-role in protective lung ventilatory strategies. Intensive Care Med 2004; 30:347-356.
48. Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344:699-709.
49. Neil-Dwyer G, Walter P, Cruickshank JM, et al. Effect of propranolol and phentolamine on myocardial necrosis after subarachnoid haemorrhage. BMJ 1978; 2:990-992.
50. Neil-Dwyer G, Walter P, Cruickshank JM. Beta-blockade benefits patients following a subarachnoid haemorrhage. Eur J Clin Pharmacol 1985; 28(Suppl): 25-29.
51. Knudsen F, Jensen HP, Petersen PL. Neurogenic pulmonary edema: treatment with dobutamine. Neurosurgery 1991; 29:269-270.
52. Deehan SC, Grant IS. Haemodynamic changes in neurogenic pulmonary oedema: effect of dobutamine. Intensive Care Med 1996; 22:672-676.
53. Joseph M, Ziadi S, Nates J, et al. Increases in cardiac output can reverse flow deficits from vasospasm independent of blood pressure: a study using xenon computed tomographic measurement of cerebral blood flow. Neurosurgery 2003; 53:1044-1051; discussion 1051-2. This study demonstrates dobutamine may be useful in vasospasm.
54. Ewig S, Torres A, El-Ebiary M, et al. Bacterial colonization patterns in mechanically ventilated patients with traumatic and medical head injury. Incidence, risk factors, and association with ventilator-associated pneumonia. Am J Respir Crit Care Med 1999; 159:188-198.
55. Sirvent JM, Torres A, Vidaur L, et al. Tracheal colonisation within 24 h of intubation in patients with head trauma: risk factor for developing early-onset ventilator-associated pneumonia. Intensive Care Med 2000; 26:1369-1372.
56. Sirvent JM, Torres A, El-Ebiary M, et al. Protective effect of intravenously administered cefuroxime against nosocomial pneumonia in patients with structural coma. Am J Respir Crit Care Med 1997; 155:1729-1734.
57. Campbell W, Hendrix E, Schwalbe R, et al. Head-injured patients who are nasal carriers of Staphylococcus aureus are at high risk for Staphylococcus aureus pneumonia. Crit Care Med 1999; 27:798-801.
58. Laupland KB, Conly JM. Treatment of Staphylococcus aureus colonization and prophylaxis for infection with topical intranasal mupirocin: an evidence-based review. Clin Infect Dis 2003; 37:933-938.
59. Heard SO, Fink MP, Gamelli RL, et al. Effect of prophylactic administration of recombinant human granulocyte colony-stimulating factor (filgrastim) on the frequency of nosocomial infections in patients with acute traumatic brain injury or cerebral hemorrhage. The Filgrastim Study Group. Crit Care Med 1998; 26:748-754.
60. The Acute Respiratory Distress Syndrome Network: Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000; 342: 1301-1308.
61. Salim A, Miller K, Dangleben D, et al. High-frequency percussive ventilation: an alternative mode of ventilation for head-injured patients with adult respiratory distress syndrome. J Trauma 2004; 57:542-546. A small series demonstrating improved oxygenation and ventilation with high frequency ventilation.
62. Huynh T, Messer M1 Sing RF, et al. Positive end-expiratory pressure alters ntracranial and cerebral perfusion pressure in severe traumatic brain injury. J Trauma 2002; 53:488-492; discussion 492-3.
63. Videtta W, Villarejo F, Cohen M, et al. Effects of positive end-expiratory pressure on intracranial pressure and cerebral perfusion pressure. Acta Neurochir Suppl 2002; 81:93-97.